Replies to post #215720 on Biotech Values

[DewDiligence]

MDGL—MRI-PDFF data from GILD’s GS-0976 for comparison:

MRI-PDFF reduction for $GILD ACC. $MDGL 3196 seems to stack up favorobly against it pic.twitter.com/DKY1cgyA9K

— M (@bio_clouseau) December 6, 2017

[Titan V]

Madrigal's stock soars on promising PhII data in NASH, but questions linger
https://endpts.com/madrigals-stock-soars-on-phase-ii-data-in-nash/

[mcbio]

MDGL -

Here is the data table that was not copied in the earlier post.

We just don't know for certain that kind of reduction in MRI-PDFF will result in resolution of NASH, do we? Isn't the ultimate key endpoint a resolution of NASH and not just an improvement?